2014
-
Financial
Osiris Therapeutics, Inc. Reports Preliminary 2014 and 2015 Revenue and Anticipated 2016 Revenue
COLUMBIA, Md., Nov. 07, 2016 (GLOBE NEWSWIRE) — Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading regenerative medicine company focused on developing…
Read More » -
Financial
Arrhythmia Research Technology Reports 12.8% Net Sales Growth and 5.1 Point Margin Expansion in 2014
FITCHBURG, Mass., March 20, 2015 (GLOBE NEWSWIRE) — Arrhythmia Research Technology, Inc. (NYSE MKT:HRT) (the “Company”), through its wholly-owned subsidiary,…
Read More » -
Financial
TiGenix reports its full year 2014 results
TiGenix NV (Euronext Brussels: TIG), an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from its proprietary platform…
Read More » -
Financial
Making sense of healthcare M&A in 2014
By Adam Cohen Healthcare M&A in 2014 was characterized by seismic changes. More than 40 deals were announced or closed…
Read More » -
Financial
Year in review: CEOs chime in on 2014
December 23, 2014 by MassDevice staff MassDevice.com asks medical device CEOs about the key issues of 2014 and what’s ahead…
Read More » -
2014 Med Device Outlook
Medical device market lukewarm in 2014 Demand is down in the U.S. but picking up in markets like Asia 2014…
Read More »